Handheld analyzer maker 908 Devices Inc's Q3 revenue beats estimates

908 Devices Inc reported Q3 revenue of $14 million, exceeding analyst expectations of $13.60 million despite a 4% year-over-year decline. The adjusted EBITDA loss improved by 53% quarter-over-quarter, but the net loss of $15 million missed estimates. The company forecasts full-year 2025 revenue between $54 million and $56 million, with potential impacts from a U.S. Government shutdown. Analyst ratings are strong, with a median 12-month price target of $10.00, reflecting a 26.2% upside from the recent closing price of $7.38.

)

Overview

908 Devices Q3 revenue decreases 4% yr/yr but beats analyst expectations
Adjusted EBITDA loss improves 53% quarter over quarter
Net loss for Q3 misses analyst estimates

Outlook

Company expects full-year 2025 revenue between $54.0 mln and $56.0 mln
Company sees potential impact from U.S. Government shutdown on award timing

Result Drivers

FTIR DEMAND - Significant quarter-over-quarter increase in XplorIR placements and initial shipments of new VipIR device
REVENUE CHANNEL DIVERSITY - 47% of revenues from U.S. state and local channels, reducing reliance on federal contracts

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Beat $14 mln $13.60

Revenue mln (4

Analysts

)

Q3 Net Miss -$15 mln -$4.29

Income mln (3

Analysts

)

Q3 Gross $7.40

Profit mln

Q3 $23.70

Operatin mln

Expenses

Analyst Coverage

The current average analyst rating on the shares is “strong buy” and the breakdown of recommendations is 4 “strong buy” or “buy”, no “hold” and no “sell” or “strong sell”
The average consensus recommendation for the advanced medical equipment & technology peer group is “buy.”
Wall Street’s median 12-month price target for 908 Devices Inc is $10.00, about 26.2% above its November 7 closing price of $7.38

Press Release: For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact . (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)